FDA panel greenlights Moderna's COVID-19 vaccine


An advisory panel for the Food and Drug Administration determined on Thursday it would recommend the agency authorize Moderna's COVID-19 vaccine, saying the benefits outweighed the risks associated with the highly-effective vaccine candidate.
The recommendation is a major step in getting a second vaccine approved for emergency use, following the FDA's authorization of the Pfizer/BioNTech vaccine last week. The FDA reportedly plans to authorize Moderna's vaccine on Friday, which would allow 5.9 million doses to begin shipment to 3,285 locations around the United States. Moderna's vaccine makes for simpler distribution than Pfizer's because it does not require ultra-cold storage conditions. The smaller batches can be stored in regular freezers, making it more accessible to hospitals in less-populated areas.
Wednesday marked yet another record in the country's daily COVID-19 case count and death toll. The federal government has purchased 200 million doses of Moderna's vaccine. Read more at The Washington Post and The New York Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
Zohran Mamdani: the young progressive likely to be New York City's next mayor
In The Spotlight The policies and experience that led to his meteoric rise
-
The best film reboots of all time
The Week Recommends Creativity and imagination are often required to breathe fresh life into old material
-
'More must be done'
Instant Opinion Opinion, comment and editorials of the day
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia